Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck snags Astellas' U.S. rights to IV vernakalant
Merck snags Astellas' U.S. rights to IV vernakalant
Merck snags Astellas' U.S. rights to IV vernakalant
Submitted by
admin
on July 27, 2011 - 2:39pm
Source:
Fierce Biotech
News Tags:
Vernakalant
Merck
Astellas
atrial fibrillation
Headline:
Merck snags Astellas' U.S. rights to IV vernakalant
Do Not Allow Advertisers to Use My Personal information
